EcoR1 Capital, Director: Aktis Oncology AKTS Buy · Filed 01/12

Trade details

Type: Insider buy
Amount: $2,599,974
Shares · price: 144,443 sh · $18.00 a share
Held after: 347,305 sh
Stock: Aktis Oncology AKTS
Person: EcoR1 CapitalDirector
Trade date: 26/01/12
Filed: 26/01/12
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 17 insiders
Holding change: +71.2%

Aktis Oncology trades, last 26 weeks

What else happened in Aktis Oncology around then

Filed or reported within 30 days of the trade day · 25/12/13~02/11

EcoR1 Capital's recent trades

EcoR1 Capital10% Owner
BuyAtara Biotherapeutics
Buy
Atara Biotherapeutics
ATRA
$4.7M
507,407 sh
$4.7M
Filed 05/11
Traded 05/07
EcoR1 Capital10% Owner
SellFirst Tracks Biotherapeutics
Sell
First Tracks Biotherapeutics
TRAX
$65M
4,705,575 sh
$65M
Filed 04/22
Traded 04/20
EcoR1 CapitalDirector
BuyAktis Oncology
Buy
Aktis Oncology
AKTS
$37.4M
2,077,779 sh
$37.4M
Filed 01/12
Traded 01/12
EcoR1 Capital10% Owner
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$3.7M
33,931,740 sh
$3.7M
Filed 25/07/30
Traded 25/07/28
EcoR1 Capital10% Owner
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$2.7M
27,433,338 sh
$2.7M
Filed 25/07/30
Traded 25/07/30

EcoR1 Capital, Director — bought $2.6M of Aktis Oncology AKTS · 144,443 sh @ $18.00 | Whalegun